TAOK1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.04379999590998E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.7407999999941E-05 |
Normal-vs-Stage2 |
2.31579999999676E-05 |
Normal-vs-Stage3 |
2.56490051420144E-10 |
Normal-vs-Stage4 |
4.30720004107599E-09 |
Stage1-vs-Stage2 |
3.264000E-01 |
Stage1-vs-Stage3 |
2.462100E-03 |
Stage1-vs-Stage4 |
4.638900E-03 |
Stage2-vs-Stage3 |
2.045200E-01 |
Stage2-vs-Stage4 |
1.814800E-01 |
Stage3-vs-Stage4 |
8.073800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.92549999675518E-08 |
Normal-vs-AfricanAmerican |
3.97760000492298E-08 |
Normal-vs-Asian |
7.486000E-01 |
Caucasian-vs-AfricanAmerican |
7.815900E-02 |
Caucasian-vs-Asian |
1.104240E-01 |
AfricanAmerican-vs-Asian |
3.140200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.31279999596268E-08 |
Normal-vs-Female |
8.76280000006169E-07 |
Male-vs-Female |
4.110400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.430500E-04 |
Normal-vs-Age(41-60Yrs) |
1.19659999997523E-06 |
Normal-vs-Age(61-80Yrs) |
2.32120000998037E-09 |
Normal-vs-Age(81-100Yrs) |
3.96040000000264E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.320400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.098000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.771400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.012760E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.066800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.976000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.555200E-01 |
Normal-vs-Grade 2 |
1.57231999999841E-05 |
Normal-vs-Grade 3 |
4.74379999726438E-08 |
Normal-vs-Grade 4 |
4.55450011038749E-10 |
Grade 1-vs-Grade 2 |
2.870400E-01 |
Grade 1-vs-Grade 3 |
1.174950E-01 |
Grade 1-vs-Grade 4 |
1.608170E-02 |
Grade 2-vs-Grade 3 |
1.481820E-01 |
Grade 2-vs-Grade 4 |
4.835400E-03 |
Grade 3-vs-Grade 4 |
8.091800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.566800E-04 |
Normal-vs-ccB subtype |
6.40130000006955E-07 |
ccA subtype-vs-ccB subtype |
7.493800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.5898999995474E-07 |
Normal-vs-N1 |
1.209800E-01 |
N0-vs-N1 |
7.369000E-01 |
|
|